Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001797537-21-000002
Filing Date
2021-06-17
Accepted
2021-06-17 17:23:17
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7495
  Complete submission text file 0001797537-21-000002.txt   8945
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY, SUITE 150 MALVERN PA 19355
Business Address
Potti Manish (Reporting) CIK: 0001797537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36751 | Film No.: 211025884